|[September 05, 2014]
Research and Markets: Global Oligonucleotide Synthesis (Equipment, Reagents & Synthesized Oligonucleotides) Market 2014-2019 - Product & Services, End-User, Application Analysis
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5nlm2g/oligonucleotide)
has announced the addition of the "Oligonucleotide
Synthesis Market by Product & Services, End-User , Application - Global
Forecast to 2019" report to their offering.
The global oligonucleotide synthesis market is expected to reach
$1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a
CAGR of 9.8% from 2014 to 2019.
Oligonucleotide synthesis has a vast number of applications in nucleic
acid array-based technologies, library preparations, next-generation
sequencing methods, genomics, nucleic acid-based detection, cell
cultures, diagnostics, therapeutics, human identity testing, cloning and
genetic engineering, and synthetic biology, among others. Apart from the
growing applications of oligos, increasing R&D expenditure in
pharmaceutical and biotechnology companies, the evolving significance of
RNA-interference oligos in therapeutics and diagnostics, increasing
venture capitalist and governmental funding and support, and rapid
technological innovations are other factors driving this market's
growth. The relatively-untapped Asia-Pacific market, and the growth in
magnitude of R&D activities in the region, has opened an array of
opportunities for players in the oligonucleotide synthesis market.
However, regulatory barriers, especially for therapeutic oligos, and
downward pricing pressure are the major factors restraining the growth
of this market.
By products and services, the market is broadly segmented into
equipment, reagents, and synthesized oligonucleotides. Among these
segments, the synthesized oligonucleotides market segment is expected to
register the highest growth rate during the forecast period, owing to
the increasing number of applications of synthesized oligonucleotides in
research, diagnostics and therapeutics, and a growing demand for custom
The market, by applications, is classified into diagnostics, research,
and therapeutics. Research applications are further segmented into PCR (News - Alert),
qPCR, sequencing, gene synthesis, and others. The therapeutics market is
further segmented into DNA/antisense oligos, RNAi, aptamers, and others.
In terms of applications, the research segment commanded the largest
share in 2014, while the diagnostics segment is expected to be the
fastest-growing segment in the oligonucleotide synthesis market. The
therapeutics segment is gaining increasing importance with growing RNAi
applications. However, stringent regulatory requirements pose a major
challenge for this market.
By end users, the market is segmented into academic research institutes,
pharmaceutical and biotech firms, and diagnostic labs. Academic research
institutes accounted for the largest share of the market in 2014;
however, diagnostic laboratories are expected to be the fastest-growing
end user segment during the forecast period, owing to growth in the
molecular diagnostics field.
Scope of the Report
By Products & Services
By Product Type
By Service Type
By End User
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Biosearch Technologies, Inc.
Eurofins Genomics (A Subsidiary of Eurofins Scientific Group)
Eurogentec (A Subsidiary of Kaneka Corporation)
GE Healthcare (A Subsidiary of General Electric Company)
Integrated Dna Technologies
Trilink Biotechnologies, Inc.
Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/5nlm2g/oligonucleotide
[ Back To TMCnet.com's Homepage ]